Response to "concerns about the statistical methodology described in the 'clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors'"

Wei Wang¹

Affiliations

Comment

Wei Wang. Prenat Diagn. 2013 Dec.

. 2013 Dec;33(13):1314-5.

doi: 10.1002/pd.4261.

Wei Wang¹

No abstract available

Comment on

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.
Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, Lau TK, Xie J, Zhao W, Huang H, Xie J, Sun L, Zhang X, Wang W, Liao S, Qiang R, Cao J, Zhang Q, Zhou Y, Zhu H, Zhong M, Guo Y, Lin L, Gao Z, Yao H, Zhang H, Zhao L, Jiang F, Chen F, Jiang H, Li S, Li Y, Wang J, Wang J, Duan T, Su Y, Zhang X. Dan S, et al. Prenat Diagn. 2012 Dec;32(13):1225-32. doi: 10.1002/pd.4002. Epub 2012 Nov 9. Prenat Diagn. 2012. PMID: 23138752 Clinical Trial.
Comment on "technical concerns on the clinical validation of the NIFTY test".
Patsalis PC, Christopoulou G, Velissariou V. Patsalis PC, et al. Prenat Diagn. 2013 Dec;33(13):1308-9. doi: 10.1002/pd.4146. Prenat Diagn. 2013. PMID: 23619941 No abstract available.